Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Pharmacology

• Publication date

  2015-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13012PMID 25393148PMCID PMC4376450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  2014cited by this paper
• Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.

  2014cited by this paper
• A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Enzymes

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Ion Channels

  2013cited by this paper
• Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.

  2013cited by this paper
• Repeated Low-Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1–Mediated Antinociceptive and Gastroprotective Effects

  2013influential reference
• Cardiovascular effects of common analgesics.

  2013cited by this paper
• Brain Levels of Prostaglandins, Endocannabinoids, and Related Lipids Are Affected by Mating Strategies

  2013cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cited by this paper
• Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.

  2013influential reference
• An efficient randomised, placebo‐controlled clinical trial with the irreversible fatty acid amide hydrolase‐1 inhibitor PF‐04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

  2012cited by this paper
• Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions.

  2012influential reference
• Recent Advances in the Pharmacological Management of Pain

  2012cited by this paper
• Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

  2012influential reference
• Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

  2011cited by this paper
• Quantitative methods for assessing drug synergism.

  2011cited by this paper
• Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

  2011cited by this paper
• Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation

  2011cited by this paper
• Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.

  2011cited by this paper
• Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice.

  2010cited by this paper
• Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanisms.

  2010cited by this paper
• Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

  2010cited by this paper
• Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

  2010cited by this paper
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways

  2009cited by this paper
• Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

  2009influential reference
• Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

  2009influential reference
• Review article: cellular and molecular mechanisms of NSAID‐induced peptic ulcers

  2009cited by this paper
• TRPA1 acts as a cold sensor in vitro and in vivo

  2009cited by this paper
• Cyclooxygenases: structural and functional insights Research on COX structure and function in the authors' laboratory is supported by grants from the National Institutes of Health (CA-89450 and GM-15431). Published, JLR Papers in Press, October 23, 2008.

  2009cited by this paper
• Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.

  2009cited by this paper
• AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors.

  2008cited by this paper
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008influential reference
• Prion protein insertional mutations increase aggregation propensity but not fiber stability

  2008cited by this paper
• Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.

  2007cited by this paper
• The impact of neuropathic pain on health-related quality of life

  2007cited by this paper
• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol

  2007cited by this paper
• TRPM8 Mechanism of Cold Allodynia after Chronic Nerve Injury

  2007cited by this paper
• The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice

  2007influential reference
• The social consequences for older people of neuropathic pain: a qualitative study.

  2007cited by this paper
• Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain.

  2006cited by this paper
• The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.

  2006cited by this paper
• An Overview of Drug Combination Analysis with Isobolograms

  2006cited by this paper
• EFNS guidelines on pharmacological treatment of neuropathic pain

  2006cited by this paper
• Immune and glial cell factors as pain mediators and modulators.

  2005cited by this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004cited by this paper
• Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment.

  2004cited by this paper
• Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin.

  2004cited by this paper
• Upregulation of spinal cannabinoid‐1‐receptors following nerve injury enhances the effects of Win 55,212‐2 on neuropathic pain behaviors in rats

  2003cited by this paper
• Pharmacology of oral combination analgesics: rational therapy for pain

  2001cited by this paper
• Spared nerve injury: an animal model of persistent peripheral neuropathic pain

  2000cited by this paper
• Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.

  1999cited by this paper
• Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.

  1997cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996cited by this paper
• Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia.

  1994cited by this paper
• Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain

  1994cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988influential reference

• Anti-inflammatory and analgesic potential of minor cannabinoids in vivo.

  2026cites this paper
• The Role of the Endocannabinoid System in the Mechanism of Action of Nonopioid Analgesics.

  2025cites this paper
• Combined Endocannabinoid and Cyclooxygenase Inhibition Additively Attenuates Post-Surgical Pain

  2025cites this paper
• SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation

  2024cites this paper
• Endocannabinoids regulate enteric neuron–glia networks and visceral hypersensitivity following inflammation through a glial‐dependent mechanism

  2024cites this paper
• Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy

  2022influential citation
• Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis

  2021influential citation
• Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.

  2021cites this paper
• Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain

  2020cites this paper
• Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

  2020cites this paper
• An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)

  2020cites this paper
• Combatting joint pain and inflammation by dual inhibition of monoacylglycerol lipase and cyclooxygenase-2 in a rat model of osteoarthritis

  2020cites this paper
• Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

  2019cites this paper
• Behavioral and Anti-inflammatory Effects of MAGL Inhibition in a Mouse Model of Inflammatory Arthritis

  2019influential citation
• Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators

  2018cites this paper
• WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms

  2018cites this paper
• Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors

  2018cites this paper
• Potential of Endocannabinoids to Control Bladder Pain

  2018cites this paper
• Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.

  2018influential citation
• Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

  2018cites this paper
• Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2018cites this paper
• Monoacylglycerol lipase (MAGL) as a promising therapeutic target.

  2018cites this paper
• Therapeutic Effect of the Substrate-Selective COX-2 Inhibitor IMMA in the Animal Model of Chronic Constriction Injury

  2018cites this paper
• Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

  2018cites this paper
• MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice

  2017cites this paper
• The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice

  2017cites this paper
• Inhibiting the Cannabinoid Catabolic Enzyme MAGL to Potentiate the Anti-Arthritic Properties of the Synthetic Glucocorticoid Dexamethasone

  2017cites this paper
• Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms

  2017cites this paper
• Clinical studies and anti‐inflammatory mechanisms of treatments

  2017cites this paper
• Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.

  2017cites this paper
• Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.

  2016cites this paper
• Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo

  2016cites this paper
• Opioid and cannabinoid synergy in a mouse neuropathic pain model

  2016cites this paper
• Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model

  2016cites this paper
• Monoglyceride lipase: Structure and inhibitors.

  2016cites this paper
• Endocannabinoid modulation of secretory and inflammatory causes of gastric pathology

  2016cites this paper
• Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches

  2016cites this paper
• Fatty acids, endocannabinoids and inflammation.

  2016cites this paper
• Regulation of inflammation by cannabinoids, the endocannabinoids 2‐arachidonoyl‐glycerol and arachidonoyl‐ethanolamide, and their metabolites

  2015cites this paper
• Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation*

  2015cites this paper